Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells

Kidney Int. 2001 Aug;60(2):484-94. doi: 10.1046/j.1523-1755.2001.060002484.x.

Abstract

Background: Polycystic kidney disease (PKD) is characterized by the abnormal proliferation of tubular epithelial cells. It was recently shown that the growth of PKD cyst-lining cells is stimulated by cyclic adenosine monophosphate (cAMP), whereas the growth of normal human kidney cortex cells is inhibited.

Methods: We have examined the effects of overexpressing the C-terminal cytosolic tail of mouse polycystin-1, as a membrane-targeted fusion protein, on cAMP-responsive cell proliferation in stably transfected M-1 cortical collecting duct cells. Two cell lines that express high levels of the polycystin-1 fusion protein and two control cell lines that do not express the fusion protein were tested.

Results: Growth of parental M-1 cells and the control cell lines was inhibited by 8-Br-cAMP and by a variety of cAMP agonists. In contrast, growth of the polycystin-1-expressing clones was stimulated by cAMP. Consistent with this, the protein kinase A (PKA) inhibitor H-89 caused either a positive or a negative growth effect depending on the primary response to cAMP. PD98059 blocked the cAMP stimulation of cell proliferation, indicating that the pathway is MEK1 dependent.

Conclusions: Expression of the polycystin-1 C-terminal tail disrupts normal cellular signaling and transforms the stably transfected M-1 cells to an abnormal PKD cell proliferation phenotype.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cell Line
  • Cyclic AMP / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression / physiology
  • Isoquinolines / pharmacology
  • Kidney Tubules, Collecting / cytology
  • Mice
  • Phenotype
  • Polycystic Kidney Diseases / genetics*
  • Polycystic Kidney Diseases / metabolism*
  • Proteins / genetics*
  • Proteins / metabolism*
  • RNA, Messenger / analysis
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction / physiology
  • Sulfonamides*
  • TRPP Cation Channels
  • Transfection

Substances

  • Enzyme Inhibitors
  • Flavonoids
  • Isoquinolines
  • Proteins
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Sulfonamides
  • TRPP Cation Channels
  • polycystic kidney disease 1 protein
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one